» Articles » PMID: 35976326

NeuroCOVID-19: a Critical Review

Overview
Publisher Thieme
Specialties Neurology
Psychiatry
Date 2022 Aug 17
PMID 35976326
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The COVID-19 pandemic has challenged neurologists since its early days. Neurology consultation services were then overloaded by emergency department and intensive-care patients with acute neurological syndromes. These complications are better explained today, but the growing number of patients with reported longstanding neurological symptoms constitute an emerging, complex, and still poorly understood phenomenon.

Objective: This review summarizes data on relevant neurological manifestations of acute SARS-CoV-2 infection and lasting post-infectious disease, also known as Long COVID. The complex history of Long COVID is examined to illustrate the upsides and challenges imposed by the active participation of patient communities in the production of medical knowledge.

Methods: Narrative review.

Results: Infection with the severe acute respiratory syndrome coronavirus 2 is associated with encephalopathy/delirium, cerebrovascular disease, headache, and peripheral nervous system involvement. Long COVID is a living concept jointly defined by patient communities, physicians and scientists, including neurologists.

Conclusion: Co-production of Long COVID knowledge between scientists and patients has initiated an era of patient-led research and evidence-based activism that acts as a two-edged sword - putting patient's suffering in the spotlight, but with a tradeoff in methodological consistency.

Citing Articles

Addressing Long COVID Sequelae and Neurocovid: Neuropsychological Scenarios and Neuroimaging Findings.

Celeghin A, Stanziano M, Palermo S Adv Exp Med Biol. 2024; 1457:143-164.

PMID: 39283425 DOI: 10.1007/978-3-031-61939-7_8.


Lowered Delta Activity in Post-COVID-19 Patients with Fatigue and Cognitive Impairment.

Ortelli P, Quercia A, Cerasa A, Dezi S, Ferrazzoli D, Sebastianelli L Biomedicines. 2023; 11(8).

PMID: 37626724 PMC: 10452696. DOI: 10.3390/biomedicines11082228.


Acute Necrotizing Encephalopathy in Adult Patients With COVID-19: A Systematic Review of Case Reports and Case Series.

Karami S, Khalaj F, Sotoudeh H, Tajabadi Z, Shahidi R, Habibi M J Clin Neurol. 2023; 19(6):597-611.

PMID: 37455513 PMC: 10622717. DOI: 10.3988/jcn.2022.0431.

References
1.
Gagnier J, Kienle G, Altman D, Moher D, Sox H, Riley D . The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013; 7:223. PMC: 3844611. DOI: 10.1186/1752-1947-7-223. View

2.
Carberry N, Badu H, Ulane C, Beckley A, Rosenberg S, Brenner K . Mononeuropathy Multiplex After COVID-19. J Clin Neuromuscul Dis. 2021; 23(1):24-30. DOI: 10.1097/CND.0000000000000367. View

3.
Stefanou M, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas G . Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022; 13:20406223221076890. PMC: 8859684. DOI: 10.1177/20406223221076890. View

4.
Keddie S, Pakpoor J, Mousele C, Pipis M, Machado P, Foster M . Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2020; 144(2):682-693. PMC: 7799186. DOI: 10.1093/brain/awaa433. View

5.
Gorna R, MacDermott N, Rayner C, OHara M, Evans S, Agyen L . Long COVID guidelines need to reflect lived experience. Lancet. 2020; 397(10273):455-457. PMC: 7755576. DOI: 10.1016/S0140-6736(20)32705-7. View